Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Sep;80(3):812-7.
doi: 10.1172/JCI113138.

Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension

Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension

B Egan et al. J Clin Invest. 1987 Sep.

Abstract

Multiple components of vascular alpha adrenergic responsiveness were investigated in twenty-four men with mild hypertension and eighteen age- and weight-matched normotensive controls. Arterial plasma norepinephrine (paNE), an index of sympathetic drive, was increased in hypertensives compared to normotensives (mean +/- SE), 199 +/- 24 vs. 134 +/- 11 pg/ml, P less than 0.02. The effective concentration of intra-arterial (iaNE) increasing forearm vascular resistance (FAVR) 30% (NE-EC30, an index of vascular alpha-receptor sensitivity) was similar in normotensives and hypertensives, 9 +/- 1 vs. 13 +/- 3 ng/100 ml per min, respectively, P greater than 0.3. The phentolamine induced reduction in FAVR, an index of vascular alpha-tone, was greater in hypertensives, -21.3 +/- 1.8 vs. normotensives, -14.9 +/- 1.2 U, P less than 0.02. We interpret these data as evidence for normal vascular alpha-receptor sensitivity to norepinephrine in mild hypertensives. Consequently, the increased sympathetic drive in mild hypertensives explains the elevated vascular alpha-tone. Although vascular alpha-receptor sensitivity to iaNE was normal, the FAVR responses at high doses (reactivity) were greater in hypertensives to regional infusion of both NE and angiotensin II. This "nonspecific" enhancement of vascular reactivity is probably explained by structural vascular changes in hypertensives.

PubMed Disclaimer

References

    1. J Clin Endocrinol Metab. 1969 Oct;29(10):1349-55 - PubMed
    1. Acta Physiol Scand Suppl. 1970;343:1-56 - PubMed
    1. Clin Exp Pharmacol Physiol. 1974 Jan-Feb;1(1):65-76 - PubMed
    1. Am J Cardiol. 1975 Oct 31;36(5):708-15 - PubMed
    1. N Engl J Med. 1977 Feb 24;296(8):405-11 - PubMed

Publication types

Substances